Literature DB >> 27921340

Brain activation during fear extinction predicts exposure success.

Tali Manber Ball1, Sarah E Knapp1, Martin P Paulus1,2, Murray B Stein1,3,4.   

Abstract

BACKGROUND: Exposure therapy, a gold-standard treatment for anxiety disorders, is assumed to work via extinction learning, but this has never been tested. Anxious individuals demonstrate extinction learning deficits, likely related to less ventromedial prefrontal cortex (vmPFC) and more amygdala activation, but the relationship between these deficits and exposure outcome is unknown. We tested whether anxious individuals who demonstrate better extinction learning report greater anxiety reduction following brief exposure.
METHODS: Twenty-four adults with public speaking anxiety completed (1) functional magnetic resonance imaging during a conditioning paradigm, (2) a speech exposure session, and (3) anxiety questionnaires before and two weeks postexposure. Extinction learning was assessed by comparing ratings to a conditioned stimulus (neutral image) that was previously paired with an aversive noise against a stimulus that had never been paired. Robust regression analyses examined whether brain activation during extinction learning predicted anxiety reduction two weeks postexposure.
RESULTS: On average, the conditioning paradigm resulted in acquisition and extinction effects on stimulus ratings, and the exposure session resulted in reduced anxiety two weeks post-exposure. Consistent with our hypothesis, individuals with better extinction learning (less negative stimulus ratings), greater activation in vmPFC, and less activation in amygdala, insula, and periaqueductal gray reported greater anxiety reduction two weeks postexposure.
CONCLUSION: To our knowledge, this is the first time that the theoretical link between extinction learning and exposure outcome has been demonstrated. Future work should examine whether extinction learning can be used as a prognostic test to determine who is most likely to benefit from exposure therapy.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  SAD/social anxiety disorder/social phobia; anxiety/anxiety disorders; behavior therapy; brain imaging/neuroimaging; functional MRI; phobia/phobic disorders

Mesh:

Year:  2016        PMID: 27921340     DOI: 10.1002/da.22583

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  20 in total

1.  Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.

Authors:  Ian A Cook; Aimee M Hunter; Marissa M Caudill; Michelle J Abrams; Andrew F Leuchter
Journal:  J Psychiatr Res       Date:  2020-02-26       Impact factor: 4.791

2.  Neural responses during extinction learning predict exposure therapy outcome in phobia: results from a randomized-controlled trial.

Authors:  Iris Lange; Liesbet Goossens; Stijn Michielse; Jindra Bakker; Bram Vervliet; Machteld Marcelis; Marieke Wichers; Jim van Os; Therese van Amelsvoort; Koen Schruers
Journal:  Neuropsychopharmacology       Date:  2019-07-28       Impact factor: 7.853

3.  Role of Human Ventromedial Prefrontal Cortex in Learning and Recall of Enhanced Extinction.

Authors:  Joseph E Dunsmoor; Marijn C W Kroes; Jian Li; Nathaniel D Daw; Helen B Simpson; Elizabeth A Phelps
Journal:  J Neurosci       Date:  2019-02-19       Impact factor: 6.167

4.  Transcranial direct current stimulation targeting the medial prefrontal cortex modulates functional connectivity and enhances safety learning in obsessive-compulsive disorder: Results from two pilot studies.

Authors:  Thomas G Adams; Josh M Cisler; Benjamin Kelmendi; Jamilah R George; Stephen A Kichuk; Christopher L Averill; Alan Anticevic; Chadi G Abdallah; Christopher Pittenger
Journal:  Depress Anxiety       Date:  2021-08-31       Impact factor: 6.505

5.  Neurobiological Alterations in Females With PTSD: A Systematic Review.

Authors:  Elizabeth Eder-Moreau; Xi Zhu; Chana T Fisch; Maja Bergman; Yuval Neria; Liat Helpman
Journal:  Front Psychiatry       Date:  2022-06-13       Impact factor: 5.435

6.  Single doses of a highly selective inhibitor of phosphodiesterase 1 (lenrispodun) in healthy volunteers: a randomized pharmaco-fMRI clinical trial.

Authors:  Sahib S Khalsa; Teresa A Victor; Rayus Kuplicki; Hung-Wen Yeh; Kimberly E Vanover; Martin P Paulus; Robert E Davis
Journal:  Neuropsychopharmacology       Date:  2022-04-29       Impact factor: 8.294

Review 7.  Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders.

Authors:  Kerry J Ressler
Journal:  Am J Psychiatry       Date:  2020-03-01       Impact factor: 18.112

8.  Altered functional activations of prefrontal brain areas during emotional processing of fear in Inuit adolescents exposed to environmental contaminants.

Authors:  Vickie Lamoureux-Tremblay; Mélissa Chauret; Gina Muckle; Françoise Maheu; Sabrina Suffren; Sandra W Jacobson; Joseph L Jacobson; Pierre Ayotte; Franco Lepore; Dave Saint-Amour
Journal:  Neurotoxicol Teratol       Date:  2021-03-16       Impact factor: 3.763

Review 9.  Neuroimaging Predictors and Mechanisms of Treatment Response in Social Anxiety Disorder: an Overview of the Amygdala.

Authors:  Heide Klumpp; Jacklynn M Fitzgerald
Journal:  Curr Psychiatry Rep       Date:  2018-08-28       Impact factor: 8.081

Review 10.  Is there a neuroscience-based, mechanistic rationale for transcranial direct current stimulation as an adjunct treatment for posttraumatic stress disorder?

Authors:  C R Faucher; R A Doherty; N S Philip; A S M Harle; J J E Cole; M Van't Wout-Frank
Journal:  Behav Neurosci       Date:  2021-08-02       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.